
The change in total and low-density lipoprotein cholesterol levels failed to exclude a potential benefit of flaxseed supplementation based on a prespecified minimum clinically important reduction of 10 percent.
"Until its relevance is clearly understood, flaxseed supplementation remains an unverified strategy for the clinical management of cardiovascular risk factors in youth with hyperlipidemia," the study concludes.
Editor's Note: This study was supported by a grant from the Labatt Family Innovation Fund. Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Source-Newswise
No comments:
Post a Comment